Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N; OPTIMAS investigators. Werring DJ, et al. Among authors: caverly e. Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4. Online ahead of print. Lancet. 2024. PMID: 39491870 Free article.
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial.
Mittal P, Gafoor R, Sayar Z, Efthymiou M, Tohidi-Esfahani I, Appiah-Cubi S, Arachchillage DJ, Atkinson D, Bordea E, Cardoso MJ, Caverly E, Chandratheva A, Chau M, Freemantle N, Gates C, Ja Ger HR, Kaul A, Mitchell C, Nguyen H, Packham B, Paskell J, Patel JP, Round C, Sanna G, Zaidi A, Werring DJ, Isenberg D, Cohen H. Mittal P, et al. Among authors: caverly e. Res Pract Thromb Haemost. 2024 Jun 5;8(5):102468. doi: 10.1016/j.rpth.2024.102468. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39139554 Free PMC article.
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
Best JG, Arram L, Ahmed N, Balogun M, Bennett K, Bordea E, Campos MG, Caverly E, Chau M, Cohen H, Dehbi HM, Doré CJ, Engelter ST, Fenner R, Freemantle N, Hunter R, James M, Lip GY, Murray ML, Norrving B, Sprigg N, Veltkamp R, Zaczyk I, Werring DJ; OPTIMAS investigators. Best JG, et al. Among authors: caverly e. Int J Stroke. 2022 Jun;17(5):583-589. doi: 10.1177/17474930211057722. Epub 2022 Jan 12. Int J Stroke. 2022. PMID: 35018878
Epithelium-off corneal cross-linking surgery compared with standard care in 10- to 16-year-olds with progressive keratoconus: the KERALINK RCT.
Larkin DFP, Chowdhury K, Doré CJ, Bunce C, Burr JM, Caverly E, French L, Kopsini D, Klepacz A, Raynor M, Edwards M, Tuft SJ. Larkin DFP, et al. Among authors: caverly e. Southampton (UK): NIHR Journals Library; 2021 Oct. Southampton (UK): NIHR Journals Library; 2021 Oct. PMID: 34644043 Free Books & Documents. Review.
Effect of Corneal Cross-linking versus Standard Care on Keratoconus Progression in Young Patients: The KERALINK Randomized Controlled Trial.
Larkin DFP, Chowdhury K, Burr JM, Raynor M, Edwards M, Tuft SJ, Bunce C, Caverly E, Doré C; KERALINK Trial Study Group. Larkin DFP, et al. Among authors: caverly e. Ophthalmology. 2021 Nov;128(11):1516-1526. doi: 10.1016/j.ophtha.2021.04.019. Epub 2021 Apr 21. Ophthalmology. 2021. PMID: 33892046 Free article. Clinical Trial.
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R, Nugent D, Bennett K, Doré CJ, Murray ML, Meadows J, Haddow LJ, Lacey C, Sandmann F, Jit M, Soldan K, Tetlow M, Caverly E, Nathan M, Copas AJ. Gilson R, et al. Among authors: caverly e. Health Technol Assess. 2020 Sep;24(47):1-86. doi: 10.3310/hta24470. Health Technol Assess. 2020. PMID: 32975189 Free PMC article. Clinical Trial.
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.
Jones A, Muller P, Dore CJ, Ikeji F, Caverly E, Chowdhury K, Isenberg DA, Gordon C, Ehrenstein MR. Jones A, et al. Among authors: caverly e. BMJ Open. 2019 Dec 16;9(12):e032569. doi: 10.1136/bmjopen-2019-032569. BMJ Open. 2019. PMID: 31848169 Free PMC article. Clinical Trial.